In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

We performed a pilot study including rituximab (Mabthera; IDEC-C2B8, Hoffmann-La Roche) with a sequential high-dose therapy protocol in 15 patients with follicular and three patients with mantle cell lymphoma and studied the potential of the chemoimmunotherapy to induce depletion of malignant B cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Voso, Maria Teresa (VerfasserIn) , Pantel, Gitta (VerfasserIn) , Weis, Mirjam (VerfasserIn) , Schmidt, Petra (VerfasserIn) , Martin, Simona (VerfasserIn) , Moos, Marion (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Haas, Rainer (VerfasserIn) , Hohaus, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [2000]
In: British journal of haematology
Year: 2000, Jahrgang: 109, Heft: 4, Pages: 729-735
ISSN:1365-2141
DOI:10.1046/j.1365-2141.2000.02084.x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1046/j.1365-2141.2000.02084.x
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2141.2000.02084.x
Volltext
Verfasserangaben:Maria Teresa Voso, Gitta Pantel, Mirjam Weis, Petra Schmidt, Simona Martin, Marion Moos, Anthony D. Ho, Rainer Haas and Stefan Hohaus

MARC

LEADER 00000caa a2200000 c 4500
001 1782688064
003 DE-627
005 20220820100654.0
007 cr uuu---uuuuu
008 211221s2000 xx |||||o 00| ||eng c
024 7 |a 10.1046/j.1365-2141.2000.02084.x  |2 doi 
035 |a (DE-627)1782688064 
035 |a (DE-599)KXP1782688064 
035 |a (OCoLC)1341436566 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Voso, Maria Teresa  |e VerfasserIn  |0 (DE-588)1152044893  |0 (DE-627)101326522X  |0 (DE-576)498652718  |4 aut 
245 1 0 |a In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma  |c Maria Teresa Voso, Gitta Pantel, Mirjam Weis, Petra Schmidt, Simona Martin, Marion Moos, Anthony D. Ho, Rainer Haas and Stefan Hohaus 
264 1 |c [2000] 
300 |b Diagramme 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Frontdoor: 24 December 2001 
500 |a Gesehen am 21.12.2021 
520 |a We performed a pilot study including rituximab (Mabthera; IDEC-C2B8, Hoffmann-La Roche) with a sequential high-dose therapy protocol in 15 patients with follicular and three patients with mantle cell lymphoma and studied the potential of the chemoimmunotherapy to induce depletion of malignant B cells in vivo. Our treatment protocol included induction with three cycles of CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) chemotherapy, followed by peripheral blood stem cell (PBSC) mobilization using high-dose cytosine arabinoside (2 g/m2 every 12 h, days 1 and 2) and mitoxantrone (10 mg/m2, days 2 and 3) (HAM), preceeded by rituximab (375 mg/m2). The proportion of CD19+ B cells in blood and bone marrow decreased from 1·2 ± 0·4% to 0·13 ± 0·1% (P = 0·01) and from 2·7 ± 0·8% to 0·8 ± 0·5% (P = 0·03) respectively. The number of t(14;18)-positive cells in blood and bone marrow progressively decreased with treatment, as assessed by the quantitative real-time PCR assay in four patients. Conversion to PCR-negativity was achieved in the peripheral blood (PB) of seven informative patients. Leucaphereses were performed during the granulocyte colony-stimulating factor (G-CSF)-supported leucocyte recovery phase. In 17 of 18 patients, a median of 15·1 × 106 CD34+ cells/kg body weight (BW) could be harvested by a single procedure for enrichment by an immunomagnetic method. Leucapheresis products contained 51·3 ± 28·8 × 104 CD19+ B cells/kg BW (mean) and were t(14;18) PCR negative in all seven informative patients. These data compare favourably with results obtained in patients treated with the same regimen without rituximab. The high-dose therapy (n = 12 patients), including total body irradiation (14·4 Gy) and cyclophosphamide (200 mg/kg BW), was also preceeded by rituximab. Recovery of neutrophils to > 0·5 × 109/l and of platelets to > 20 × 109/l required a median of 13·5 and 11·5 d (range 11-24 and 9-24 d) respectively. In conclusion, the addition of the CD20 antibody to chemotherapy ensured tumour depletion in vivo and allowed the collection of PBSCs devoid of tumour cells and with conserved engraftment capability. 
650 4 |a follicular lymphoma 
650 4 |a real-time PCR 
650 4 |a Rituximab 
700 1 |a Pantel, Gitta  |d 1975-  |e VerfasserIn  |0 (DE-588)128751371  |0 (DE-627)379128225  |0 (DE-576)297313878  |4 aut 
700 1 |a Weis, Mirjam  |e VerfasserIn  |4 aut 
700 1 |a Schmidt, Petra  |e VerfasserIn  |4 aut 
700 1 |a Martin, Simona  |d 1963-  |e VerfasserIn  |0 (DE-588)123077974  |0 (DE-627)706152034  |0 (DE-576)293545456  |4 aut 
700 1 |a Moos, Marion  |e VerfasserIn  |0 (DE-588)1243124318  |0 (DE-627)1773573187  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Haas, Rainer  |d 1955-  |e VerfasserIn  |0 (DE-588)173773524  |0 (DE-627)698678141  |0 (DE-576)134613805  |4 aut 
700 1 |a Hohaus, Stefan  |e VerfasserIn  |0 (DE-588)1084809745  |0 (DE-627)848733983  |0 (DE-576)168163020  |4 aut 
773 0 8 |i Enthalten in  |t British journal of haematology  |d Oxford [u.a.] : Wiley-Blackwell, 1955  |g 109(2000), 4, Seite 729-735  |h Online-Ressource  |w (DE-627)269758941  |w (DE-600)1475751-5  |w (DE-576)09113997X  |x 1365-2141  |7 nnas  |a In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma 
773 1 8 |g volume:109  |g year:2000  |g number:4  |g pages:729-735  |g extent:7  |a In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma 
856 4 0 |u https://doi.org/10.1046/j.1365-2141.2000.02084.x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2141.2000.02084.x  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211221 
993 |a Article 
994 |a 2000 
998 |g 1084809745  |a Hohaus, Stefan  |m 1084809745:Hohaus, Stefan  |p 9  |y j 
998 |g 173773524  |a Haas, Rainer  |m 173773524:Haas, Rainer  |p 8 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 1243124318  |a Moos, Marion  |m 1243124318:Moos, Marion  |d 910000  |d 910100  |e 910000PM1243124318  |e 910100PM1243124318  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 123077974  |a Martin, Simona  |m 123077974:Martin, Simona  |d 50000  |e 50000PM123077974  |k 0/50000/  |p 5 
998 |g 1152044893  |a Voso, Maria  |m 1152044893:Voso, Maria  |p 1  |x j 
999 |a KXP-PPN1782688064  |e 402363350X 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title_sort":"In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma","title":"In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma"}],"person":[{"family":"Voso","given":"Maria Teresa","display":"Voso, Maria Teresa","role":"aut"},{"role":"aut","display":"Pantel, Gitta","given":"Gitta","family":"Pantel"},{"role":"aut","family":"Weis","given":"Mirjam","display":"Weis, Mirjam"},{"role":"aut","family":"Schmidt","display":"Schmidt, Petra","given":"Petra"},{"role":"aut","family":"Martin","display":"Martin, Simona","given":"Simona"},{"role":"aut","family":"Moos","display":"Moos, Marion","given":"Marion"},{"family":"Ho","given":"Anthony Dick","display":"Ho, Anthony Dick","role":"aut"},{"family":"Haas","display":"Haas, Rainer","given":"Rainer","role":"aut"},{"role":"aut","display":"Hohaus, Stefan","given":"Stefan","family":"Hohaus"}],"recId":"1782688064","origin":[{"dateIssuedKey":"2000","dateIssuedDisp":"[2000]"}],"name":{"displayForm":["Maria Teresa Voso, Gitta Pantel, Mirjam Weis, Petra Schmidt, Simona Martin, Marion Moos, Anthony D. Ho, Rainer Haas and Stefan Hohaus"]},"relHost":[{"note":["Gesehen am 08.05.08"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"4","extent":"7","pages":"729-735","year":"2000","volume":"109","text":"109(2000), 4, Seite 729-735"},"id":{"eki":["269758941"],"zdb":["1475751-5"],"doi":["10.1111/(ISSN)1365-2141"],"issn":["1365-2141"]},"title":[{"title_sort":"British journal of haematology","subtitle":"BJHaem : an official journal of the British Society for Haematology","title":"British journal of haematology"}],"corporate":[{"role":"isb","display":"British Society for Haematology"},{"display":"European Hematology Association","role":"isb"}],"origin":[{"dateIssuedKey":"1955","publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedDisp":"1955-"}],"name":{"displayForm":["ed. R. B. Thompson [u.a.]"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1955 -"],"language":["eng"],"titleAlt":[{"title":"the official journal of the British Society of Haematology"},{"title":"BJH ; the official journal of the British Society for Haematology"}],"recId":"269758941","disp":"In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphomaBritish journal of haematology"}],"note":["Frontdoor: 24 December 2001","Gesehen am 21.12.2021"],"physDesc":[{"extent":"7 S.","noteIll":"Diagramme"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1046/j.1365-2141.2000.02084.x"],"eki":["1782688064"]}} 
SRT |a VOSOMARIATINVIVODEPL2000